Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-09

FDA Approved: ZENATANE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approves a supplemental application for ZENATANE (isotretinoin) submitted by BluePoint Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZENATANE (Isotretinoin)

Snippet

SUPPL AP for ZENATANE (ISOTRETINOIN)